Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel E Furst

Showing results (101-110 of 477) with videos related to

Pageof 48
Sort By:
Muscle & Nerve|September 19, 2012
Medical costs and health-care resource use in patients with inflammatory myopathies in an insured populationDaniel E Furst, Anthony A Amato, Serban R Iorga, et al.
Rheumatology (Oxford, England)|July 23, 2015
Final 10-year effectiveness and safety results from study DE020: adalimumab treatment in patients with rheumatoid arthritis and an inadequate response to standard therapyDaniel E Furst, Arthur Kavanaugh, Stefan Florentinus, et al.
Drug Safety|November 8, 2019
Rheumatology Common Toxicity Criteria (RCTC): An Update Reflecting Real-World UseChristian M Stach, Victor S Sloan, Thasia G Woodworth, et al.
Rheumatology (Oxford, England)|October 10, 2017
Points to consider when doing a trial primarily involving the heartYannick Allanore, Oliver Distler, Ulrich A Walker, et al.
Rheumatology (Oxford, England)|October 10, 2017
Interstitial lung disease points to consider for clinical trials in systemic sclerosisDinesh Khanna, James Seibold, Jonathan Goldin, et al.
Seminars in Arthritis and Rheumatism|July 9, 2019
Questioning a publication bias between industry-funded and non-industry-funded randomized controlled trials on biological and small molecule therapy for rheumatoid arthritisNeta Cohen, Ronnie Gur Lavie, Ya'ara Manor, et al.
Rheumatology (Oxford, England)|October 10, 2017
Points to consider for skin ulcers in systemic sclerosisFelice Galluccio, Yannick Allanore, Lázló Czirjak, et al.
Rheumatology and Therapy|March 19, 2020
Repository Corticotropin Injection for Active Rheumatoid Arthritis Despite Aggressive Treatment: A Randomized Controlled Withdrawal TrialRoy Fleischmann, Daniel E Furst, Erin Connolly-Strong, et al.
Cells|July 11, 2025
Mesenchymal Stem-Cell-Derived Exosomes and MicroRNAs: Advancing Cell-Free Therapy in Systemic SclerosisCristiano Barbetta, Francesco Bonomi, Gemma Lepri, et al.
Joint Bone Spine|December 10, 2016
Hydroxychloroquine and joint involvement in systemic sclerosis: Preliminary beneficial results from a retrospective case-control series of an EUSTAR centerCosimo Bruni, Emanuela Praino, Serena Guiducci, et al.
Pageof 48

Showing results (101-110 of 477) with videos related to

Sort By:
Pageof 48
Muscle & Nerve|September 19, 2012
Medical costs and health-care resource use in patients with inflammatory myopathies in an insured populationDaniel E Furst, Anthony A Amato, Serban R Iorga, et al.
Rheumatology (Oxford, England)|July 23, 2015
Final 10-year effectiveness and safety results from study DE020: adalimumab treatment in patients with rheumatoid arthritis and an inadequate response to standard therapyDaniel E Furst, Arthur Kavanaugh, Stefan Florentinus, et al.
Drug Safety|November 8, 2019
Rheumatology Common Toxicity Criteria (RCTC): An Update Reflecting Real-World UseChristian M Stach, Victor S Sloan, Thasia G Woodworth, et al.
Rheumatology (Oxford, England)|October 10, 2017
Points to consider when doing a trial primarily involving the heartYannick Allanore, Oliver Distler, Ulrich A Walker, et al.
Rheumatology (Oxford, England)|October 10, 2017
Interstitial lung disease points to consider for clinical trials in systemic sclerosisDinesh Khanna, James Seibold, Jonathan Goldin, et al.
Seminars in Arthritis and Rheumatism|July 9, 2019
Questioning a publication bias between industry-funded and non-industry-funded randomized controlled trials on biological and small molecule therapy for rheumatoid arthritisNeta Cohen, Ronnie Gur Lavie, Ya'ara Manor, et al.
Rheumatology (Oxford, England)|October 10, 2017
Points to consider for skin ulcers in systemic sclerosisFelice Galluccio, Yannick Allanore, Lázló Czirjak, et al.
Rheumatology and Therapy|March 19, 2020
Repository Corticotropin Injection for Active Rheumatoid Arthritis Despite Aggressive Treatment: A Randomized Controlled Withdrawal TrialRoy Fleischmann, Daniel E Furst, Erin Connolly-Strong, et al.
Cells|July 11, 2025
Mesenchymal Stem-Cell-Derived Exosomes and MicroRNAs: Advancing Cell-Free Therapy in Systemic SclerosisCristiano Barbetta, Francesco Bonomi, Gemma Lepri, et al.
Joint Bone Spine|December 10, 2016
Hydroxychloroquine and joint involvement in systemic sclerosis: Preliminary beneficial results from a retrospective case-control series of an EUSTAR centerCosimo Bruni, Emanuela Praino, Serena Guiducci, et al.
Pageof 48